The Policy Atlas — where the country actually stands on psychedelics

The interactive map

Explore every state.

Switch layers — including five leaderboards (harm reduction, research, therapeutic access, decriminalization, equity), play the time-lapse, and click any state for its full scorecard and the small steps it could take to rise.

Find my state → do one thing Open full-screen ↗ Embed this on your site

The scoreboard

Five ways to lead.

Overall openness is the headline — but a state can lead the country in any one of these. Pick a board and find where your state ranks. Open it on the map above for the exact steps to climb.

Each board is a transparent 0–100 index built from sourced fields, then ranked #1–#50 (ties share a rank; D.C. is shown but not ranked). Ketamine is excluded — it's legal in every state, so it can't separate them. Educational only, not legal advice.

Local resources

Find your people.

A directory of 460+ real organizations across all 50 states plus D.C. — reform and decriminalization groups, harm-reduction services, research centers, psychedelic societies, veteran programs, and more. Pick your state, or search by name or city.

Every organization was verified to have a live web presence in 2026. Listing is informational, not an endorsement, and not legal advice. Know a group we missed? Tell us on Get Involved.

The prize

Each year, the most elevated state earns the Ball.

This is a scoreboard, not just a map. The state that climbs the rankings the most in a year becomes a finalist to host A Tripping Ball — an upscale night of science, comedy, and celebration. Move your state up, and you earn it. Here's how to climb: open any state on the map for its exact next steps.

Updates from around the country

What's moving right now.

The national picture is shifting fast. Here's the headline momentum, plus a live pull of what's in motion in each active state.

Industry
Eli Lilly places a $3.8B bet on psychedelics — the field's largest pharma investment yet.
Colorado
Regulated psilocybin healing centers are now operational under the state's Natural Medicine program.
North Carolina
Lawmakers advance a $4.2M university psychedelic-research bill (Duke / UNC), alongside UNC's $26.9M DARPA program.
Arizona
The state funds $5M for ibogaine and $5M for psilocybin research — among the largest public commitments yet.
Research
23 states now host active psychedelic research programs — from Johns Hopkins to UW–Madison to UNM's Phase 3 trials.
FDA
Regulators continue fast-tracking psychedelic therapies, with multiple Phase 3 programs in progress.

On the move · by state

Educational only, not legal advice. State movement is pulled from the atlas dataset; figures are best-effort and should be verified against primary sources (Psychedelic Alpha, MPP, NORML) before relying on them. This feed refreshes as the underlying data is updated.